BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35796138)

  • 1. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
    Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
    Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
    Janhunen O; Jokelainen O; Peltoniemi R; Nykopp TK; Arponen O
    Acta Oncol; 2024 May; 63():330-338. PubMed ID: 38745483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
    Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
    Noguchi G; Kawahara T; Kobayashi K; Tsutsumi S; Ohtake S; Osaka K; Umemoto S; Nakaigawa N; Uemura H; Kishida T; Yao M
    PLoS One; 2020; 15(1):e0226581. PubMed ID: 31895931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
    Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
    J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
    Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT anthropometric analysis of the prognosis of traumatic brain injury: A retrospective study to compare between psoas muscle and abdominal skeletal muscle.
    Cho HJ; Hwang Y; Yang SY; Kim M
    Injury; 2022 May; 53(5):1652-1657. PubMed ID: 35241285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization.
    Zhang JX; Yan HT; Ding Y; Liu J; Liu S; Zu QQ; Shi HB
    Ann Med; 2022 Dec; 54(1):1562-1569. PubMed ID: 35639492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia measurements and clinical outcomes in Crohn's disease surgical patients.
    Hong JT; James S; Tran A; Kutaiba N
    ANZ J Surg; 2022 Dec; 92(12):3209-3213. PubMed ID: 36156838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorsal Muscle Attenuation May Predict Failure to Respond to Interleukin-2 Therapy in Metastatic Renal Cell Carcinoma.
    Otemuyiwa B; Derstine BA; Zhang P; Wong SL; Sabel MS; Redman BG; Wang SC; Alva AS; Davenport MS
    Acad Radiol; 2017 Sep; 24(9):1094-1100. PubMed ID: 28341412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
    McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
    Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma.
    Aslan V; Kılıç ACK; Sütcüoğlu O; Eraslan E; Bayrak A; Öksüzoğlu B; Tahtacı G; Özdemir N; Üner A; Günel N; Özet A; Yazıcı O
    Urol Oncol; 2022 Nov; 40(11):494.e1-494.e10. PubMed ID: 36137881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between computed tomography derived skeletal muscle index, psoas muscle index and clinical outcomes in patients with operable colorectal cancer.
    Abbass T; Tsz Ho YT; Horgan PG; Dolan RD; McMillan DC
    Clin Nutr ESPEN; 2020 Oct; 39():104-113. PubMed ID: 32859302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
    Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
    Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia Is Associated With Aggressive Clinicopathological Outcomes and Is a Poor Prognostic Indicator for Non-metastatic Renal Cell Carcinoma.
    Makino T; Izumi K; Iwamoto H; Kadomoto S; Kadono Y; Mizokami A
    In Vivo; 2023; 37(3):1304-1311. PubMed ID: 37103104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma.
    Herrmann T; Mione C; Montoriol PF; Molnar I; Ginzac A; Durando X; Mahammedi H
    Oncology; 2022; 100(2):114-123. PubMed ID: 34999587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer.
    Yoshikawa N; Shirakawa A; Yoshida K; Tamauchi S; Suzuki S; Kikkawa F; Kajiyama H
    Nutr Clin Pract; 2020 Dec; 35(6):1041-1046. PubMed ID: 32253779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy.
    Ozawa Y; Nakano T; Taniyama Y; Sakurai T; Onodera Y; Kamiya K; Hikage M; Sato C; Takaya K; Konno T; Unno M; Kamei T
    Esophagus; 2019 Oct; 16(4):345-351. PubMed ID: 30980203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
    Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
    Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.